130 related articles for article (PubMed ID: 11294519)
21. The long-term retention of platinum in human tissues following the administration of cisplatin or carboplatin for cancer chemotherapy.
Tothill P; Klys HS; Matheson LM; McKay K; Smyth JF
Eur J Cancer; 1992; 28A(8-9):1358-61. PubMed ID: 1515251
[TBL] [Abstract][Full Text] [Related]
22. High performance liquid chromatographic determination of platinum in blood and urine samples of cancer patients after administration of cisplatin drug using solvent extraction and N,N'-bis(salicylidene)-1,2-propanediamine as complexation reagent.
Lanjwani SN; Zhu R; Khuhawar MY; Ding Z
J Pharm Biomed Anal; 2006 Mar; 40(4):833-9. PubMed ID: 16181764
[TBL] [Abstract][Full Text] [Related]
23. Tumor-tissue and plasma concentrations of platinum during chemotherapy of non-small-cell lung cancer patients.
Pujol JL; Cupissol D; Gestin-Boyer C; Bres J; Serrou B; Michel FB
Cancer Chemother Pharmacol; 1990; 27(1):72-5. PubMed ID: 2173980
[TBL] [Abstract][Full Text] [Related]
24. Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivors.
Hjelle LV; Bremnes RM; Gundersen POM; Sprauten M; Brydøy M; Tandstad T; Wilsgaard T; Fosså SD; Oldenburg J; Haugnes HS
Urol Oncol; 2016 Nov; 34(11):487.e13-487.e20. PubMed ID: 27523611
[TBL] [Abstract][Full Text] [Related]
25. Plasma pharmacokinetics and tissue and brain distribution of cisplatin in musk shrews.
Eiseman JL; Beumer JH; Rigatti LH; Strychor S; Meyers K; Dienel S; Horn CC
Cancer Chemother Pharmacol; 2015 Jan; 75(1):143-52. PubMed ID: 25398697
[TBL] [Abstract][Full Text] [Related]
26. Serum creatinine and cholesterol levels of testicular cancer patients in long-term follow up.
Hisamatsu E; Kawai K; Hinotsu S; Miyanaga N; Shimazui T; Akaza H
Int J Urol; 2005 Aug; 12(8):751-6. PubMed ID: 16174050
[TBL] [Abstract][Full Text] [Related]
27. Long-term serum platinum changes and their association with cisplatin-related late effects in testicular cancer survivors.
Hjelle LV; Gundersen POM; Hellesnes R; Sprauten M; Brydøy M; Tandstad T; Wilsgaard T; Fosså SD; Oldenburg J; Bremnes RM; Haugnes HS
Acta Oncol; 2018 Oct; 57(10):1392-1400. PubMed ID: 29775128
[TBL] [Abstract][Full Text] [Related]
28. Kinetics of plasma platinum in a hemodialysis patient receiving repeated doses of cisplatin.
Hirai K; Ishiko O; Sumi T; Kanaoka Y; Ogita S
Oncol Rep; 2000; 7(6):1243-5. PubMed ID: 11032923
[TBL] [Abstract][Full Text] [Related]
29. Validated method for the determination of platinum from a liposomal source (SPI-77) in human plasma using graphite furnace Zeeman atomic absorption spectrometry.
Meerum Terwogt JM; Tibben MM; Welbank H; Schellens JH; Beijnen JH
Fresenius J Anal Chem; 2000 Feb; 366(3):298-302. PubMed ID: 11225675
[TBL] [Abstract][Full Text] [Related]
30. Metallomics in drug development: characterization of a liposomal cisplatin drug formulation in human plasma by CE-ICP-MS.
Nguyen TT; Østergaard J; Stürup S; Gammelgaard B
Anal Bioanal Chem; 2013 Feb; 405(6):1845-54. PubMed ID: 23052859
[TBL] [Abstract][Full Text] [Related]
31. Noninvasive follow-up of platinum pharmacokinetics in the skin of patients on cisplatin chemotherapy.
Gorodetsky R; Mou X; Vexler A; Kaufman B; Catane R; Loewenthal E
Cancer; 1993 Jul; 72(2):446-54. PubMed ID: 8319176
[TBL] [Abstract][Full Text] [Related]
32. Isolated lung perfusion with platinum in the treatment of pulmonary metastases from soft tissue sarcomas.
Ratto GB; Toma S; Civalleri D; Passerone GC; Esposito M; Zaccheo D; Canepa M; Romano P; Palumbo R; De Cian F; Scarano F; Vannozzi M; Spessa E; Fantino G
J Thorac Cardiovasc Surg; 1996 Sep; 112(3):614-22. PubMed ID: 8800147
[TBL] [Abstract][Full Text] [Related]
33. Inductively coupled plasma mass spectrometric analysis of the total amount of platinum in DNA extracts from peripheral blood mononuclear cells and tissue from patients treated with cisplatin.
Brouwers EE; Tibben MM; Pluim D; Rosing H; Boot H; Cats A; Schellens JH; Beijnen JH
Anal Bioanal Chem; 2008 May; 391(2):577-85. PubMed ID: 18385987
[TBL] [Abstract][Full Text] [Related]
34. Determination of cis-diamminedichloroplatinum (II) in plasma proteins and hemoglobin of cancer patients.
Mustonen R; Hietanen P; Leppälä S; Takala M; Hemminki K
Arch Toxicol; 1989; 63(5):361-6. PubMed ID: 2818200
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of inductively coupled mass spectrometry for the determination of platinum in plasma.
Allain P; Berre S; Mauras Y; Le Bouil A
Biol Mass Spectrom; 1992 Mar; 21(3):141-3. PubMed ID: 1576172
[TBL] [Abstract][Full Text] [Related]
36. Platinum exposure and cause-specific mortality among patients with testicular cancer.
Groot HJ; van Leeuwen FE; Lubberts S; Horenblas S; de Wit R; Witjes JA; Groenewegen G; Poortmans PM; Hulshof MCCM; Meijer OWM; de Jong IJ; van den Berg HA; Smilde TJ; Vanneste BGL; Aarts MJB; Jóźwiak K; van den Belt-Dusebout AW; Gietema JA; Schaapveld M
Cancer; 2020 Feb; 126(3):628-639. PubMed ID: 31730712
[TBL] [Abstract][Full Text] [Related]
37. Measurement of platinum in saliva of patients treated with cisplatin.
Holding JD; Lindup WE; Roberts NB; Salvatori P; Stell PM
Ann Clin Biochem; 1999 Sep; 36 ( Pt 5)():655-9. PubMed ID: 10505218
[TBL] [Abstract][Full Text] [Related]
38. Unravelling mechanisms of cisplatin sensitivity and resistance in testicular cancer.
Koster R; van Vugt MA; Timmer-Bosscha H; Gietema JA; de Jong S
Expert Rev Mol Med; 2013 Sep; 15():e12. PubMed ID: 24074238
[TBL] [Abstract][Full Text] [Related]
39. Population pharmacokinetic analysis of cisplatin and its metabolites in cancer patients: possible misinterpretation of covariates for pharmacokinetic parameters calculated from the concentrations of unchanged cisplatin, ultrafiltered platinum and total platinum.
Hanada K; Nishijima K; Ogata H; Atagi S; Kawahara M
Jpn J Clin Oncol; 2001 May; 31(5):179-84. PubMed ID: 11450990
[TBL] [Abstract][Full Text] [Related]
40. Clinical pharmacology of intraperitoneal cisplatin.
Lopez JA; Krikorian JG; Reich SD; Smyth RD; Lee FH; Issell BF
Gynecol Oncol; 1985 Jan; 20(1):1-9. PubMed ID: 4038390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
